International Society for Cell & Gene Therapy (ISCT) 2026

Home - International Society for Cell & Gene Therapy

Let’s Connect

 

The 2026 Meeting of the International Society of Cell and Gene (ISCT) recognizes that we are living in the “Golden Age of Cell & Gene Therapy”. Accelerating innovation is combined with expanding clinical success and growing commercialization to reach patients faster than ever. As therapies mature, the industry’s focus is shifting upstream, where early decisions around the supply chain and cellular starting materials increasingly determine long‑term outcomes. At this year’s ISCT, the IntegriCell team from Cryoport Systems is engaging with global CGT leaders to address the operational realities that will help define this new era.

IntegriCell was built for staging early success. As Cryoport Systems’ integrated cryopreservation platform, IntegriCell provides purpose‑built, automated workflows designed to improve consistency and reduce variability while supporting scalable cell therapy supply chains. This year’s meeting presents multiple opportunities to meet our team and find out how we are contributing to this defining age of CGT as we share data‑driven insights on cryopreservation and upstream process standardization.

Join us for these speaking engagements and continue the discussion in person!

 

 

Join us for these events during ISCT 2026

Oral Abstract Session : Robust automated leukapheresis cryo-processing enables high-quality starting material for both autologous and allogeneic CAR-T cell therapy manufacturing

Shawne Thorsen, Process Engineer

When: Wednesday, May 6, 2026 at 11:35am – 11:45am

Location: Liffey Hall 2

Poster Presentation: Comparative evaluation of automated and conventional flow cytometry methods for characterizing leukapheresis during the cryopreservation process

Apolline Fossion, AD/QC Specialist

When: Wednesday, May 6, 2026 at 7:00pm – 8:30pm

Location: Poster #921

Poster Presentation: Ensuring robustness and scalability of automated cryopreservation for leukapheresis material to support CGT supply chains

Alice Bouchoms, Process Development Manager

When: Wednesday, May 6, 2026 at 7:00pm – 8:30pm

Location: Poster #909

Poster Presentation: Robust automated leukapheresis cryo-processing enables high-quality starting material for both autologous and allogeneic CAR-T cell therapy manufacturing

Shawne Thorsen, Process Engineer

When: Wednesday, May 6, 2026 at 7:00pm – 8:30pm

Location: Poster #18

Global Showcase Presentation: Comparative Evaluation of Automated and Conventional Flow Cytometry Methods for Leukapheresis characterization upon Cryopreservation Processes

Dominic Clarke, Vice President – Technical Operations, Integricell

When: Thursday, May 7, 2026 at 3:30pm – 3:45pm

Location: Global Showcase Theatre A

Elevator Pitch Session: Ensuring robustness and scalability of automated cryopreservation for leukapheresis material to support CGT supply chains

Alice Bouchoms, Process Development Manager

When: Thursday, May 7, 2026 at 5:00pm – 5:45pm

Location: Global Showcase Theater A

The Cryoport Systems Team

Our talented team will be live on-site, including executive leadership, business development, and product experts. We are looking forward to connecting with you in Dublin this May!

 

About Cryoport Systems

Cryoport Systems is a comprehensive supply chain partner for the life sciences industry focused on meeting the challenges of the global cell and gene therapy market. We excel in the specialized management of the biopharma supply chain through our comprehensive offerings in logistics, BioServices and biostorage, cryopreservation, and consulting. With our expansive platform and decades of temperature-controlled supply chain expertise, Cryoport Systems helps Enable the Outcome™ for advanced therapies programs, safely and securely guiding critical therapies to patients in need.

 

About the Conference

International Society for Cell & Gene Therapy Annual Meeting takes an integrative approach across all stakeholders to address key topics spanning translational research and preclinical development through to clinical trials, regulatory approvals, commercialization, and ultimately patient access.

Visit Event Site

 

Let’s Connect 

Interested in setting up a time to talk with our team of experts? Looking to follow up on a recent presentation or booth conversation? We’d love to hear from you! Fill out the form below and our team will be in touch.